west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "管圣" 2 results
  • Effectiveness and Safety of Carotid Endarterectomy Versus Carotid Artery Stenting in Treatment of Carotid Artery Stenosis: A Meta-Analysis

    Objective To update available evidence on safety and efficacy of carotid endarterectomy (CEA) versus carotid artery stenting (CAS) in treatment of carotid artery stenosis by a meta-analysis of randomized controlled trials (RCTs). Methods A comprehensive search was performed of PubMed, EMBASE, Cochrane Library, Web of science, WanFang, and CNKI databases (from January 1990 to July 2015), to collect articles and past systematic reviews, and then abstraced lists of recent scientific conferences which were related with safety and efficacy of CEA versus CAS in treatment of carotid artery stenosis. At last, Meta analysis was performed by RevMan 5.1 software. Results Fifteen RCTs enrolling 9 828 patients were included in the Meta-analysis. Compared with CAS, CEA was associated with a significantly lower incidences of any stroke or death within 30 days after surgery (OR=0.63, 95% CI: 0.51-0.77, P<0.05) and any stroke or death during follow-up, or ipsilateral stroke after 30 days of operation (OR=0.61, 95% CI: 0.48-0.76, P<0.05), but associated with a significantly greater incidences of myocardial infarction (OR=1.81, 95% CI: 1.14-2.87, P=0.01) and cranial neuropathy (OR=18.28, 95% CI: 7.99-41.82, P<0.05) within 30 days after surgery. Conclusion In comparison with CAS, CEA is associated with a lower incidences of stroke or death and a greater incidence of myocardial infarction and cranial neuropathy within 30 days after surgery, and was associated with a significantly lower incidence of any stroke or death during follow-up, or ipsilateral stroke after 30 days of operation. So the results of Meta-analysis support continued use of CEA as the standard method in treatment of carotid artery stenosis.

    Release date: Export PDF Favorites Scan
  • 准分子激光消蚀联合药物涂层球囊治疗下肢动脉硬化闭塞症的短期疗效

    目的评估准分子激光消蚀术(excimer laser ablation,ELA)联合药物涂层球囊(drug-coated balloon,DCB)治疗下肢动脉硬化闭塞症的疗效及安全性。方法回顾性收集2021年9月至2022年4月期间新疆维吾尔自治区人民医院血管外科收治且采用ELA联合DCB治疗的下肢动脉硬化闭塞症患者的临床病理资料,观察手术成功率,术后第3天、第3、6、12个月时的踝肱指数、一期通畅率和保趾(肢)率。结果本研究共收集到40例患者,均为单下肢病变,男30例、女10例,年龄(71.9±10.9)岁。40例患者(40条肢体)手术成功率为100%,均未出现严重的术中并发症。术后第3天、第3、6、12个月时的踝肱指数分别为0.87±0.09、0.82±0.12、0.78±0.10、0.76±0.15,较术前(0.34±0.13)均有明显提高 [均数差(95%可信区间)分别为 0.011(–0.549,–0.502)、0.013(–0.502,–0.447)、0.017(–0.473,–0.404)、0.016(–0.454,–0.385),t值分别为–46.70、–34.94、–25.55、–24.86,P值分别为<0.001、<0.001、0.035、0.048]。术后第3天、第3、6、12个月时的一期通畅率分别为100%(40/40)、97.5%(39/40)、90.0%(36/40)和82.5%(33/40),保肢(趾)率分别为95.0%(38/40)、92.5%(37/40)、92.5%(37/40)和87.5%(35/40)。结论从本组有限病例分析的结果提示,ELA联合DCB治疗下肢动脉硬化闭塞症具有较好的安全性和良好的近期疗效。

    Release date: Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content